Life Science Firm wins Funding Grant

Wide Blue 06 December 2011

A SCOTTISH life sciences firm is to share in £8.5 million of grant funding from the UK government’s Technology Strategy Board to boost research projects in the regenerative medicine sector.

Edinburgh’s ImmunoSolv will work with Wideblue, Edinburgh University, the UK Stem Cell Bank, and the Scottish Stem Cell Network. ImmunoSolv specialises in detecting and removing dead cells. Regenerative medicine is best known for focusing on diseases such as Alzheimer’s and Parkinson’s.